483 King Pharmaceuticals. Nov 2016

483 King Pharmaceuticals. Nov 2016

Emilie Kahn FDA, Emily Orban FDA, Aurora-Miha Trifanov FDA$119.00 - Available Now

FDA investigators audited the King Pharmaceuticals. - Rochester, MI, United States facility and issued inspectional observations (via FDA 483) on 21 Nov 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Nov 2016
  • Location: Rochester, United States
  • FEI: 1876582
Add To Cart